Characterization of Amyloid β Peptides in Cerebrospinal Fluid by an Automated Immunoprecipitation Procedure Followed by Mass Spectrometry
- 10 October 2007
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Proteome Research
- Vol. 6 (11), 4433-4439
- https://doi.org/10.1021/pr0703627
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Alzheimer's diseaseThe Lancet, 2006
- The ADAMs family: Coordinators of nervous system development, plasticity and repairProgress in Neurobiology, 2006
- Natural oligomers of the amyloid-β protein specifically disrupt cognitive functionNature Neuroscience, 2004
- Cerebrospinal Fluid Profile of Amyloid β Peptides in Patients with Alzheimer’s Disease Determined by Protein Biochip TechnologyNeurodegenerative Diseases, 2004
- Cell biology of protein misfolding: The examples of Alzheimer's and Parkinson's diseasesNature, 2004
- Cerebrospinal fluid amyloid β peptide patterns in Alzheimer's disease patients and nondemented controls depend on sample pretreatment: Indication of carrier‐mediated epitope masking of amyloid β peptidesElectrophoresis, 2004
- Alzheimer's soluble amyloid β is a normal component of human urineFEBS Letters, 1997
- Visualization of Aβ42(43) and Aβ40 in senile plaques with end-specific Aβ monoclonals: Evidence that an initially deposited species is Aβ42(43)Neuron, 1994
- The carboxy terminus of the .beta. amyloid protein is critical for the seeding of amyloid formation: Implications for the pathogenesis of Alzheimer's diseaseBiochemistry, 1993
- Amyloid β-peptide is produced by cultured cells during normal metabolismNature, 1992